The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Association of Transcription Factor APRF and Protein Kinase Jak1 with the Interleukin-6 Signal Transducer gp130
Abstract
Interleukin-6 (IL-6), leukemia inhibitory factor, oncostatin M, interleukin-11, and ciliary neurotrophic factor bind to receptor complexes that share the signal transducer gp130. Upon binding, the ligands rapidly activate DNA binding of acute-phase response factor (APRF), a protein antigenically related to the p91 subunit of the interferon-stimulated gene factor-3α (ISGF-3α). These cytokines caused tyrosine phosphorylation of APRF and ISGF-3α p91. Protein kinases of the Jak family were also rapidly tyrosine phosphorylated, and both APRF and Jak1 associated with gp130. These data indicate that Jak family protein kinases may participate in IL-6 signaling and that APRF may be activated in a complex with gp130.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Both IFN␥ and IL-6 can activate JAK1 (4 -6) and JAK2 (7-10), and subsequently STAT1 (11,12) and STAT3 (6,13,14).”
From The Comparative Roles of Suppressor of Cytokine Signaling-1 and -3 in the Inhibition and Desensitization of Cytokine Signaling (2006) · cites this paper as [6]
Citations
Cites
Kessler, D. S., Veals, S. A., Fu, X. Y., & Levy, D. E. (1990) · Genes & Development · doi:10.1101/gad.4.10.1753 · Cited by 312
Flagged first, then by citations
Research works printed but not linked: 30
- 10.1016/0092-8674(93)90415-M · DOI
- BAZAN, J.F., NEUROPOIETIC CYTOKINES IN THE HEMATOPOIETIC FOLD, NEURON 7: 197 (1991). · DOI
- BAZAN, J.F., STRUCTURAL DESIGN AND MOLECULAR EVOLUTION OF A CYTOKINE RECEPTOR SUPERFAMILY, PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 87: 6934 (1990).
- COOPER, J.A., DETECTION AND QUANTIFICATION OF PHOSPHOTYROSINE IN PROTEINS, METHODS IN ENZYMOLOGY 99: 387 (1983). · DOI
- 10.1126/science.8390097 · DOI
- DECKER, T, CYTOPLASMIC ACTIVATION OF GAF, AN IFN-GAMMA-REGULATED DNA-BINDING FACTOR, EMBO JOURNAL 10: 927 (1991). · DOI
- FIRMBACHKRAFT, I, TYK2, PROTOTYPE OF A NOVEL CLASS OF NONRECEPTOR TYROSINE KINASE GENES, ONCOGENE 5: 1329 (1990).
- FU, X.Y., TRANSCRIPTION FACTOR P91 INTERACTS WITH THE EPIDERMAL GROWTH-FACTOR RECEPTOR AND MEDIATES ACTIVATION OF THE C-FOS GENE PROMOTER, CELL 74: 1135 (1993). · DOI
- 10.1126/science.1542794 · DOI
- HIBI, M, MOLECULAR-CLONING AND EXPRESSION OF AN IL-6 SIGNAL TRANSDUCER, GP130, CELL 63: 1149 (1990). · DOI · Paper page
- Hibi, M., Cell 63: 1149 (1990). · DOI · Paper page
- 10.1126/science.8378773 · DOI
- 10.1126/science.8511589 · DOI
- PATTERSON, P.H., NEURONAL DIFFERENTIATION FACTORS CYTOKINES AND SYNAPTIC PLASTICITY, CELL 72: 123 (1993). · DOI
- PELLEGRINI, S, EARLY EVENTS IN SIGNALING BY INTERFERONS, TRENDS IN BIOCHEMICAL SCIENCES 18: 338 (1993). · DOI
- 10.1126/science.8378774 · DOI
- 10.1126/science.8397445 · DOI
- SCHINDLER, C, PROTEINS OF TRANSCRIPTION FACTOR ISGF-3 - ONE GENE ENCODES THE 91-KDA AND 84-KDA ISGF-3 PROTEINS THAT ARE ACTIVATED BY INTERFERON-ALPHA, PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 89: 7836 (1992).
- 10.1126/science.1496401 · DOI · Paper page
- 10.1126/science.1281555 · DOI
- 10.1126/science.7690989 · DOI · Paper page
- SILVENNOINEN, O, STRUCTURE OF THE MURINE JAK2 PROTEIN-TYROSINE KINASE AND ITS ROLE IN INTERLEUKIN-3 SIGNAL-TRANSDUCTION, PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 90: 8429 (1993).
- STAHL, N, THE ALPHAS, BETAS, AND KINASES OF CYTOKINE RECEPTOR COMPLEXES, CELL 74: 587 (1993). · DOI
- 10.1016/0092-8674(92)90105-L · DOI
- WEGENKA, U.M., ACUTE-PHASE RESPONSE FACTOR, A NUCLEAR FACTOR BINDING TO ACUTE-PHASE RESPONSE ELEMENTS, IS RAPIDLY ACTIVATED BY INTERLEUKIN-6 AT THE POSTTRANSLATIONAL LEVEL, MOLECULAR AND CELLULAR BIOLOGY 13: 276 (1993).
- WILKS, A.F., 2 NOVEL PROTEIN-TYROSINE KINASES, EACH WITH A 2ND PHOSPHOTRANSFERASE-RELATED CATALYTIC DOMAIN, DEFINE A NEW CLASS OF PROTEIN-KINASE, MOLECULAR AND CELLULAR BIOLOGY 11: 2057 (1991).
- WITTHUHN, B.A., JAK2 ASSOCIATES WITH THE ERYTHROPOIETIN RECEPTOR AND IS TYROSINE-PHOSPHORYLATED AND ACTIVATED FOLLOWING STIMULATION WITH ERYTHROPOIETIN, CELL 74: 227 (1993). · DOI
- YOSHIMURA, A, INVITRO PHOSPHORYLATION OF THE ERYTHROPOIETIN RECEPTOR AND AN ASSOCIATED PROTEIN, PP130, MOLECULAR AND CELLULAR BIOLOGY 12: 706 (1992).
- Yuan, J., Molecular and Cellular Biology 14: 1657 (1994).
- Ip, N. Y., Cell 69: 1121 (1992). · DOI
Cited by
Sorted by citations
Items 401–500 of 704
Insulin Modulates STAT3 Protein Activation and Gene Transcription in Hepatic Cells*
Campos, S. P., Wang, Y., & Baumann, H. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.40.24418 · Cited by 39
Zaheer, A., & Lim, R. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.8.5183 · Cited by 38
STAT3beta, a distinct isoform from STAT3
Zhang, H., Yang, P.-L., Li, E., & Xu, L. (2019) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2019.02.006 · Cited by 45
Minimal role for STAT1 in interleukin‐6 signaling and actions in the murine brain
Sanz, E., Hofer, M. J., Unzeta, M., & Campbell, I. L. (2007) · Glia · doi:10.1002/glia.20602 · Cited by 35
Woldman, I., Varinou, L., Ramsauer, K., Rapp, B., & Decker, T. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m105320200 · Cited by 37
Human Interleukin-6 Facilitates Hepatitis B Virus Infection in Vitro and in Vivo
Galun, E., Nahor, O., Eid, A., Jurim, O., Rose‐John, S., Blum, H. E., Nussbaum, O., Ilan, E., Daudi, N., Shouval, D., et al. (2000) · Virology · doi:10.1006/viro.2000.0210 · Cited by 32
Targeted Disruption of the IL‐6 Related Genes: gp130 and NF‐IL‐6
Akira, S., YOSHIDA, K., Tanaka, T., Taga, T., & Kishimoto, T. (1995) · Immunological Reviews · doi:10.1111/j.1600-065x.1995.tb00100.x · Cited by 33
Self-citationInterferon-beta interrupts interleukin-6-dependent signaling events in myeloma cells.
Berger, L. C., & Hawley, R. G. (1997) · Blood · doi:10.1182/blood.v89.1.261.261_261_271 · Cited by 37
Briest, W., Rassler, B., Deten, A., Leicht, M., Morwinski, R., Neichel, D., Wallukat, G., Ziegelhöffer, T., & Zimmer, H.-G. (2003) · Pflügers Archiv · doi:10.1007/s00424-003-1043-x · Cited by 36
“Once it is activated, gp130 transiently interacts with STAT3 [ 12 ].”
BackgroundThe Impact of Donor Age on the Outcome of Adult Living Donor Liver Transplantation
Iwamoto, T., Yagi, T., Umeda, Y., Sato, D., Matsukawa, H., Matsuda, H., Shinoura, S., Sadamori, H., Mizuno, K., Yoshida, R., et al. (2008) · Transplantation · doi:10.1097/tp.0b013e31816c7e90 · Cited by 41
“In the STAT family, STAT3 is widely recognized as a strong gene promoter which induces the acute-phase reaction originating from interleukin-6 (20, 21).”
BackgroundLang, E. M., Schlegel, N., Reiners, K., Hofmann, G., Sendtner, M., & Asan, E. (2008) · Journal of Neurotrauma · doi:10.1089/neu.2007.0396 · Cited by 35
“After activation of the CNTF receptor complex, it induces both activation of akt and mitogen activated proteinkinase (MAPK) pathways, but also phosphorylation of signal transducer and activator of transcription 3 (STAT3) via januskinase 1 (jak1) (Kirsch et al., 2003; Lütticken et al., 1994).”
Self-citationRegulation of terminal differentiation of human B-cells by IL-6.
Chen-Kiang, S. (1995) · Current Topics in Microbiology and Immunology · doi:10.1007/978-3-642-79275-5_23 · Cited by 35
JAK-STAT signaling pathway in non-infectious uveitis
Su, Y., Tao, T., Liu, X., & Su, W. (2022) · Biochemical Pharmacology · doi:10.1016/j.bcp.2022.115236 · Cited by 38
MicroRNA-411 Inhibits Cervical Cancer Progression by Directly Targeting STAT3
Dan, S., Shang, Y.-M., & Hu, T. (2019) · Oncology Research · doi:10.3727/096504018x15247361080118 · Cited by 34
RetractedImpact of STAT3 phosphorylation in glioblastoma stem cells radiosensitization and patient outcome
Masliantsev, K., Pinel, B., Balbous, A., Guichet, P., Tachon, G., Milin, S., Godet, J., Duchesne, M., Berger, A., Petropoulos, C., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.23374 · Cited by 37
Li, M.-H., Zhou, X., Mei, J., Geng, X., Zhou, Y., Zhang, W., & Xu, C. (2014) · Cellular & Molecular Biology Letters · doi:10.2478/s11658-014-0188-2 · Cited by 34
Suppressor of Cytokine Signaling 3 Inhibits Breast Tumor Kinase Activation of STAT3
Gao, Y., Cimica, V., & Reich, N. C. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.334144 · Cited by 33
Nishishita, N., Ijiri, H., Takenaka, C., Kobayashi, K., Goto, K., Kotani, E., Itoh, T., Mori, H., & Kawamata, S. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2010.12.063 · Cited by 31
Genetic origins of hyper-IgE syndrome
Minegishi, Y., & Karasuyama, H. (2008) · Current Allergy and Asthma Reports · doi:10.1007/s11882-008-0075-x · Cited by 31
Prolonged insulin treatment inhibits GH signaling via STAT3 and STAT1
Xu, J., Ji, S., Venable, D. Y., Franklin, J. L., & Messina, J. L. (2005) · Journal of Endocrinology · doi:10.1677/joe.1.05977 · Cited by 31
“…184, 481–492 Downloaded from Bioscientifica.com at 11/19/2018 12:11:56PM via free access IL-6 is an important cytokine regulating induction of acute-phase response genes via activation of STAT3 (Lutticken et al. 1994), but little is known about whether GH regulates expression of acute-phase genes.”
BackgroundGrowth Control Mechanisms in Multiple Myeloma
Hawley, R. G., & Berger, L. (1998) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428199809050906 · Cited by 31
Kee, B. L., & Paige, C. J. (1995) · International Review of Cytology · doi:10.1016/s0074-7696(08)62158-0 · Cited by 34
The Ups and Downs of STAT Inhibition in Acute Myeloid Leukemia
Moser, B., Edtmayer, S., Witalisz‐Siepracka, A., & Stoiber, D. (2021) · Biomedicines · doi:10.3390/biomedicines9081051 · Cited by 35
Janus Kinase 1 Is Essential for Inflammatory Cytokine Signaling and Mammary Gland Remodeling
Sakamoto, K., Wehde, B. L., Yoo, K. H., Kim, T., Rajbhandari, N., Shin, H. Y., Triplett, A. A., Rädler, P. D., Schuler, F., Villunger, A., et al. (2016) · Molecular and Cellular Biology · doi:10.1128/mcb.00999-15 · Cited by 33
“Although it was recognized nearly 2 decades ago that JAK1 plays a role in IL-6 signaling (21, 45, 46), more recent work has singled out JAK2 as the master regulator for STAT3 activation in breast cancer and other malignancies (47–49).”
BackgroundEstrogen and progesterone regulate the IL-6 signal transduction pathway in antibody secreting cells
Canellada, A. M., Álvarez, I. R., Berod, L., & Gentile, T. (2008) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2008.06.009 · Cited by 33
Dziennis, S., & Habecker, B. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212480200 · Cited by 33
Özbek, S., Peters, M., Breuhahn, K., Mann, A., Blessing, M., Fischer, M., Schirmacher, P., Mackiewicz, A., & Rose-John, S. (2001) · Oncogene · doi:10.1038/sj.onc.1204180 · Cited by 33
Fu, X.-Y. (1995) · Journal of Leukocyte Biology · doi:10.1002/jlb.57.4.529 · Cited by 33
Signaling pathways activated by protein tyrosine phosphorylation in lymphocytes.
DeFranco, A. (1994) · Current Opinion in Immunology · doi:10.1016/0952-7915(94)90114-7 · Cited by 33
Leicht, M., Briest, W., & Zimmer, H. (2004) · Molecular and Cellular Biochemistry · doi:10.1023/a:1021655023870 · Cited by 33
Autonomic regulation of liver regeneration after partial hepatectomy in mice
Ikeda, O., Ozaki, M., Murata, S., Matsuo, R., Nakano, Y., Watanabe, M., Hisakura, K., Myronovych, A., Kawasaki, T., Kohno, K., et al. (2009) · Journal of Surgical Research · doi:10.1016/j.jss.2008.02.059 · Cited by 32
Sferra (2011) · Molecular Medicine Reports · doi:10.3892/mmr.2011.413 · Cited by 32
Zhang, T., Seow, K., Ong, C. T., & Cao, X. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m105525200 · Cited by 32
Timmermann, A., Pflanz, S., Grötzinger, J., Küster, A., Kurth, I., Pitard, V., Heinrich, P. C., & Müller-Newen, G. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)01205-9 · Cited by 32
Self-citationDefinition of a Composite Binding Site for gp130 in Human Interleukin-6 (*)
Ciapponi, L., Graziani, R., Paonessa, G., Lahm, A., Ciliberto, G., & Savino, R. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.52.31249 · Cited by 32
PC12‐E2 cells: A stable variant with altered responses to growth factor stimulation
Wu, Y. Y., & Bradshaw, R. A. (1995) · Journal of Cellular Physiology · doi:10.1002/jcp.1041640310 · Cited by 32
Salvati, A., Lahm, A., Paonessa, G., Ciliberto, G., & Toniatti, C. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.20.12242 · Cited by 32
Activating mutations of the gp130/JAK/STAT pathway in human diseases
Lokau, J., & Garbers, C. (2018) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2018.11.007 · Cited by 41
Rebollo, A., Gómez, J., & Martínez‐A, C. (1996) · Advances in immunology · doi:10.1016/s0065-2776(08)60856-1 · Cited by 28
Model-driven experimental analysis of the function of SHP-2 in IL-6-induced Jak/STAT signaling
Dittrich, A., Quaiser, T., Khouri, C., Görtz, D., Mönnigmann, M., & Schaper, F. (2012) · Molecular BioSystems · doi:10.1039/c2mb05488d · Cited by 32
STAT3/HIF-1α/fascin-1 axis promotes RA FLSs migration and invasion ability under hypoxia.
Yang, W., Wei, X., Jiao, Y.-C., Bai, Y., Sam, W. N., Yan, Q., Sun, X., Li, G.-P., Ma, J., Wei, W., et al. (2021) · Molecular Immunology · doi:10.1016/j.molimm.2021.12.004 · Cited by 31
Bhattacharjee, A., Xu, B., Frank, D., Feldman, G., & Cathcart, M. (2006) · Journal of Immunology · doi:10.4049/jimmunol.177.6.3771 · Cited by 31
Stephanou, A., Conroy, S., Isenberg, D. A., Maione, D., Poli, V., Ciliberto, G., & Latchman, D. (1998) · Journal of Autoimmunity · doi:10.1006/jaut.1998.0194 · Cited by 31
Morella, K. K., Lai, C., Kumaki, S., Kumaki, N., Wang, Y., Bluman, E. M., Witthuhn, B., Ihle, J., Giri, J., Gearing, D., et al. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.14.8298 · Cited by 31
Lack of gp130 expression in hepatocytes attenuates tumor progression in the DEN model
Hatting, M., Spannbauer, M., Peng, J., Al Masaoudi, M., Sellge, G., Nevzorova, Y. A., Gassler, N., Liedtke, C., Cubero, F. J., & Trautwein, C. (2015) · Cell Death & Disease · doi:10.1038/cddis.2014.590 · Cited by 30
Askvig, J. M., & Watt, J. A. (2015) · Journal of Cell Communication and Signaling · doi:10.1007/s12079-015-0268-8 · Cited by 36
Computational study on mechanism of G-quartet oligonucleotide T40214 selectively targeting Stat3
Zhu, Q., & Jing, N. (2007) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-007-9147-6 · Cited by 24
Hao, A.-J., Novotny-Diermayr, V., Bian, W., Lin, B., Lim, C. P., Jing, N., & Cao, X. (2005) · Molecular Biology of the Cell · doi:10.1091/mbc.e04-08-0664 · Cited by 30
Kinase Inhibitors in Cancer Therapy
Sedlacek, H. H. (2000) · Drugs · doi:10.2165/00003495-200059030-00004 · Cited by 89
“[297] The STAT3 protein associates with gp130 and JAK-1, and is rapidly tyrosine phosphorylated during the IL-6[298] or EPO response.”
InfluentialTacken, I., Dahmen, H., Boisteau, O., Minvielle, S., Jacques, Y., Grötzinger, J., Küster, A., Horsten, U., Blanc, C., Montero-Julian, F., et al. (1999) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.1999.00755.x · Cited by 30
Self-citationChrist, B., Nath, A., Heinrich, P. C., & Jungermann, K. (1994) · Hepatology · doi:10.1002/hep.1840200629 · Cited by 30
“IL-6 signal transduction occurs by way of tyrosine phosphorylation of the transcription factor acute-phase response factor (5,6).”
BackgroundSelf-citationInterferon response pathways—a paradigm for cytokine signalling?
Müller, M. M., Ibelgaufts, H., & Kerr, I. M. (1994) · Journal of Viral Hepatitis · doi:10.1111/j.1365-2893.1994.tb00109.x · Cited by 30
Potential Role for STAT3 Inhibitors in Glioblastoma
Jackson, C. M., Ruzevick, J., Amin, A. G., & Lim, M. K. (2012) · Neurosurgery Clinics of North America · doi:10.1016/j.nec.2012.04.002 · Cited by 31
Wang, K., Zhou, B., Zhang, J., Xin, Y.-L., Lai, T., Wang, Y., Hou, Q., Song, Y., Chen, Y., Quan, Y., et al. (2011) · DNA and Cell Biology · doi:10.1089/dna.2010.1179 · Cited by 29
“Janus kinase ( JAK) and signal transducer and activator of transcription (STAT) pathways transmit a wide range of signals, including cytokines, growth factors, and hormones (Lütticken et al., 1994; Levy and Darnell, 2002).”
Kalakonda, S., Nallar, S. C., Gong, P., Lindner, D. J., Goldblum, S. E., Reddy, S. P., & Kalvakolanu, D. V. (2007) · American Journal Of Pathology · doi:10.2353/ajpath.2007.070241 · Cited by 28
Tsuyama, N., Danjoh, I., Otsuyama, K., Obata, M., Tahara, H., Ohta, T., & Ishikawa, H. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.09.036 · Cited by 27
Mangan, J. K., Rane, S. G., Kang, A. D., Amanullah, A., Wong, B. C., & Reddy, E. P. (2004) · Blood · doi:10.1182/blood-2003-06-2165 · Cited by 29
Thiel, S., Sommer, U., Kortylewski, M., Haan, C., Behrmann, I., Heinrich, P. C., & Graeve, L. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)01276-x · Cited by 29
Self-citationTrautwein, C., Walker, D. L., Plümpe, J., & Manns, M. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.25.15130 · Cited by 29
Activation of the JAK-STAT3 pathway is associated with the growth of colorectal carcinoma cells
WEI, X., Wang, G., LI, W., Hu, X., HUANG, Q., Xu, K., Lou, W., Jia Rui, W. U., Chen, L., LOU, Q., et al. (2013) · Oncology Reports · doi:10.3892/or.2013.2858 · Cited by 28
Sobotta, S., Raue, A., Huang, X., Vanlier, J., Jünger, A., Bohl, S., Albrecht, U., Hahnel, M. J., Wolf, S., Mueller, N. S., et al. (2017) · Frontiers in Physiology · doi:10.3389/fphys.2017.00775 · Cited by 28
“STAT3 is activated by JAK1 only after docking to phosphorylated gp130 (Lutticken et al., 1994; Stahl et al., 1995; Yamanaka et al., 1996).”
BackgroundRegulation of IL-6-type cytokine responses by MAPKs
Costa‐Pereira, A. P. (2014) · Biochemical Society Transactions · doi:10.1042/bst20130267 · Cited by 27
Chollangi, S., Mather, T., Rodgers, K., & Ash, J. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.387324 · Cited by 28
Staršíchová, A., Lincová, E., Pernicová, Z., Kozubík, A., & Souček, K. (2010) · Cellular Signalling · doi:10.1016/j.cellsig.2010.06.014 · Cited by 28
SHPS-1/SIRP1alpha contributes to interleukin-6 signalling.
Sobota, R. M., Müller, P. J., Khouri, C., Ullrich, A., Poli, V., Noguchi, T., Heinrich, P., & Schaper, F. (2008) · Cellular Signalling · doi:10.1016/j.cellsig.2008.03.005 · Cited by 28
Self-citationBlockade of Virus Infection by Human CD4+ T Cells via a Cytokine Relay Network
Davis, A. M., Hagan, K. A., Matthews, L. A., Bajwa, G., Gill, M. A., Gale, M., & Farrar, J. D. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.10.6923 · Cited by 24
“Additionally, there are some reports detailing a population of CD4 CTLs that can directly lyse infected targets by cell-cell contact (7, 13, 14).”
BackgroundHayashi, M., Rho, M., Fukami, A., Enomoto, A., Nonaka, S., Sekiguchi, Y., Yanagisawa, T., Yamashita, A., Nogawa, T., Kamano, Y., et al. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.036137 · Cited by 28
Takashima, S., & Klagsbrun, M. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.40.24901 · Cited by 28
Regulation of STAT3 and NF-κB activations by S-nitrosylation in multiple myeloma
Kim, J., Choi, S., Saxena, N., Singh, A. K., Singh, I., & Won, J. (2017) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2017.02.039 · Cited by 28
Chou, C. H., Chen, P., Jeng, Y., Cheng, A., Huang, L., & Cheng, J. C. (2009) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2008.12.072 · Cited by 28
Identification of the domain in the human interleukin-11 receptor that mediates ligand binding.
Schleinkofer, K., Dingley, A. J., Tacken, I., Federwisch, M., Müller-Newen, G., Heinrich, P. C., Vusio, P., Jacques, Y., & Grötzinger, J. (2001) · Journal of Molecular Biology · doi:10.1006/jmbi.2000.4387 · Cited by 27
Self-citationLeukemia Inhibitory Factor Regulates Proopiomelanocortin Transcription a
Ray, D. W., Ren, S., & Melmed, S. (1998) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1998.tb09560.x · Cited by 27
Kirschning, C., Unbehaun, A., Fiedler, G., Hallatschek, W., Lamping, N., Pfeil, D., & Schumann, R. R. (1997) · Immunobiology · doi:10.1016/s0171-2985(97)80033-2 · Cited by 27
Huppertz, C., Schwartz, C., Becker, W., Horn, F., Heinrich, P. C., & Joost, H. (1996) · Diabetologia · doi:10.1007/s001250050595 · Cited by 27
“IL-6 and interferon-g activate the transcription factors acute-phase response factor (APRF)/Stat3 or Stat1, respectively, through the tyrosine kinases Jak1, Jak2 and Tyk2 [22, 23], whereas IL-4 activates Stat6 through Jak1 and Jak3 [23].”
BackgroundInfluentialSelf-citationLin, X., Li, X., Zhai, Z., & Zhang, M. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1563286 · Cited by 24
“Upon binding, this complex activates JAK2 and TYK2, which subsequently recruit and phosphorylate STATs, mainly STAT4 (126).”
InfluentialThe role of proteolysis in interleukin-11 signaling
Lokau, J., Kespohl, B., Kirschke, S., & Garbers, C. (2021) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2021.119135 · Cited by 35
Andreasen, S., Therkildsen, M. H., Grauslund, M., Friis-Hansen, L. J., Wessel, I., & Homøe, P. (2015) · Apmis · doi:10.1111/apm.12407 · Cited by 25
Ratra, R., Kar-Roy, A., & Lal, S. K. (2009) · Journal of General Virology · doi:10.1099/vir.0.009274-0 · Cited by 26
“IL-6 is the main mediator of acutephase-induced FBG synthesis (Otto et al., 1987; Lutticken et al., 1994; Zhong et al., 1994).”
BackgroundInflammation induces serine protease inhibitor 3 expression in the rat pineal gland.
Takamiya, A., Takeda, M., Yoshida, A., & Kiyama, H. (2002) · Neuroscience · doi:10.1016/s0306-4522(02)00198-7 · Cited by 26
Ishikawa, H., Mahmoud, M. S., Fujii, R., Abroun, S., & Kawano, M. M. (2000) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428190009053538 · Cited by 28
Minta, J., Fung, M. R., & Paramaswara, B. (1998) · Biochimica et Biophysica Acta · doi:10.1016/s0167-4781(98)00189-4 · Cited by 26
Regulation of Inflammation-Mediated Chronic Diseases by Botanicals
Sung, B., Prasad, S., Gupta, S. C., Patchva, S., & Aggarwal, B. B. (2012) · Advances in botanical research · doi:10.1016/b978-0-12-394591-4.00003-9 · Cited by 28
Role of the JAK/STAT Signal Transduction Pathway in the Regulation of Gene Expression in CNS
Dell’Albani, P., Santangelo, R., Torrisi, L. L., Nicoletti, V. G., & Stella, A. M. G. (2003) · Neurochemical Research · doi:10.1023/a:1021644027850 · Cited by 23
“JAK/STAT signal transduction pathway: the Janus tyrosine kinases (Jak kinases) including four cytoplasmic proteins (JAK1, JAK2, JAK3, and TYK2) that undergo tyrosine phosphorylation upon specific ligand receptor binding (1, 2 ) and the signal transducers and activators of transcription STATs, including seven cytoplasm…”
BackgroundKopantzev, Y., Heller, M., Swaminathan, N., & Rudikoff, S. (2002) · Oncogene · doi:10.1038/sj.onc.1205815 · Cited by 23
“Previous studies have indicated that Jak1, Jak2 and Tyk2 are all phosphorylated following IL-6 stimulation leading to tyrosine phosphorylation/activation of primarily STAT3 (Lutticken et al., 1994; Narazaki et al., 1994).”
BackgroundInfluentialgp130 Transducing Receptor Cross-linking Is Sufficient to Induce Interleukin-6 Type Responses (*)
Fourcin, M., Chevalier, S., Guillet, C., Robledo, O., Froger, J., Pouplard-Barthelaix, A., & Gascan, H. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.20.11756 · Cited by 25
STAT3 as a therapeutic target in the metformin-related treatment.
Zhang, W.-R., Li, D., Li, B., Chu, X., & Kong, B. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.109770 · Cited by 25
Helwig, B. G., Musch, T. I., Craig, R. A., & Kenney, M. (2006) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00507.2006 · Cited by 23
“The interaction of receptor and ligand subunits promotes rapid internalization of IL-6 (14, 22, 45) and initiation of signal transduction pathways (20, 37, 43), followed by receptor-ligand downregulation and degradation of the IL-6/IL-6R/gp130 complex (14).”
BackgroundYan, Y., Bian, W., Xie, Z., Cao, X., Roux, I. L., Guillemot, F., & Jing, N. (2004) · Developmental Dynamics · doi:10.1002/dvdy.20126 · Cited by 24
“These cytokines are known to bind to the LIFR / gp130 complex and to signal through the Jak-Stat pathway (Lutticken et al., 1994; Stahl et al., 1994; Turnley and Bartlett, 2000).”
BackgroundBöhm, M., Schulte, U., Funk, J. O., Raghunath, M., Behrmann, I., Kortylewski, M., Heinrich, P. C., Kues, T., Luger, T., & Schwarz, T. (2001) · Journal of Investigative Dermatology · doi:10.1046/j.0022-202x.2001.01372.x · Cited by 24
Self-citationPervanadate mimics IFNgamma-mediated induction of ICAM-1 expression via activation of STAT proteins.
Duff, J. L., Quinlan, K. L., Paxton, L. L., Naik, S., & Caughman, S. (1997) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12286465 · Cited by 24
Yang, Z.-M., Le, S., Chen, D.-B., Yasukawa, K., & Harper, M. J. (1995) · Journal of Reproduction and Fertility · doi:10.1530/jrf.0.1030249 · Cited by 24
Self-citationRecent advances in antitumor Pt(IV) complexes: Dual targeting and chemoimmunotherapy
Spector, D. V., Zharova, A., Bykusov, V., Karetnikov, G. L., Beloglazkina, E. K., & Krasnovskaya, O. O. (2025) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2025.216808 · Cited by 28
General Mechanisms of Cytokine Receptor Signaling
Carpenter, L. R., Yancopoulos, G. D., & Stahl, N. (1998) · Advances in protein chemistry · doi:10.1016/s0065-3233(08)60434-9 · Cited by 27
Gupta, S. K., Jollimore, C. A. B., Mclaren, M., Inana, G., & Kelly, M. E. M. (1997) · Biochemistry and cell biology = Biochimie et biologie cellulaire · doi:10.1139/o97-033 · Cited by 24
Dynamics of gene expression in rat hepatocytes under stress.
Jayaraman, A., Yarmush, M., & Roth, C. M. (2000) · Metabolic Engineering · doi:10.1006/mben.2000.0153 · Cited by 23
Qin, F., Yao, J., Zhou, G., Xia, W., Lyu, J., Li, X., Zhao, T., Zhang, G., Zhao, N., & Yang, J. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01881 · Cited by 23
“org August 2018 | Volume 9 | Article 1881 IL-6 was also involved in the induction of BNIP3 through the activation of Jak/Stat3 signaling (113, 114), and the suppression of IL-6/Jaks/Stat3 signaling might contribute to the inhibition of Bnip3-mediated apoptosis and autophagy in ConA-induced hepatitis (29).”
BackgroundYuan, K., Liu, H., Huang, L., Ren, X., Liu, J., Dong, X., Tian, W., & Jia, Y. (2014) · BioMed Research International · doi:10.1155/2014/527918 · Cited by 16
Heparin Synergistically Enhances Interleukin-11 Signaling through Up-regulation of the MAPK Pathway*
Rajgopal, R., Butcher, M. K., Weitz, J., & Shaughnessy, S. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m600169200 · Cited by 22
Finbloom, D., & Larner, A. (1995) · Arthritis & Rheumatism · doi:10.1002/art.1780380702 · Cited by 22
Glucose ingestion during endurance training in men attenuates expression of myokine receptor
Akerstrom, T. C. A., Krogh‐Madsen, R., Petersen, A. M. W., & Pedersen, B. K. (2009) · Experimental Physiology · doi:10.1113/expphysiol.2009.048983 · Cited by 21
“Interleukin-6 receptor α lacks an intracellular signalling domain and forms a complex with the ubiquitous gp130 receptor to initiate intracellular signalling (Lutticken et al. 1994).”
Background
Metadata
- Authors
- Lütticken, C., Wegenka, U. M., Yuan, J., Buschmann, J., Schindler, C., Ziemiecki, A., Harpur, A. G., Wilks, A. F., Yasukawa, K., Taga, T., Kishimoto, T., Barbieri, G., Pellegrini, S., Sendtner, M., Heinrich, P. C., & Horn, F.
- Affiliations
- RWTH Aachen University (DE)
- ORCID
- Venue
- Science
- Published
- 1994-01-07
- Volume
- 263
- Issue
- 5143
- Pages
- 89-92
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W1999028040
- Cited by
- 814
- References
- 0
- Citations by year
- 2026: 4 · 2025: 8 · 2024: 11 · 2023: 5 · 2022: 7 · 2021: 13 · 2020: 10 · 2019: 14 · 2018: 14 · 2017: 17 · 2016: 17 · 2015: 23 · 2014: 15 · 2013: 15 · 2012: 20
- FWCI
- 38.85
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- RWTH Publications (RWTH Aachen) (submittedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
- Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
- Keywords
- JAK1, gp130, IL-6 signaling, cytokine-receptor complex, tyrosine phosphorylation, transcription factor activation, leukemia inhibitory factor, oncostatin M, interleukin-11, ciliary neurotrophic factor, signal transduction
- MeSH terms
- Base Sequence, DNA-Binding Proteins, Humans, Interferon-gamma, Membrane Glycoproteins, Molecular Sequence Data, Phosphorylation, Protein-Tyrosine Kinases, Transcription Factors, Tumor Cells, Cultured, Tyrosine, Signal Transduction, Trans-Activators, Antigens, CD, Interleukin-6, Cytokines, STAT1 Transcription Factor, STAT3 Transcription Factor, Cytokine Receptor gp130, Interferon-Stimulated Gene Factor 3, Interferon-Stimulated Gene Factor 3, gamma Subunit, Janus Kinase 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review